Tumour necrosis factor-α mediates neutrophil migration to the knee synovial cavity during immune inflammation
- 2 August 2004
- journal article
- research article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 496 (1-3) , 197-204
- https://doi.org/10.1016/j.ejphar.2004.06.003
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Thalidomide: an old drug with new clinical applicationsExpert Opinion on Drug Safety, 2004
- Emerging biotherapies for inflammatory bowel diseaseEmerging Drugs, 2003
- Updated consensus statement on biological agents for the treatment of rheumatoid arthritis and other immune mediated inflammatory diseases (May 2003)Annals of the Rheumatic Diseases, 2003
- Novel therapies for the treatment of juvenile rheumatoid arthritis (juvenile idiopathic arthritis)Expert Opinion on Investigational Drugs, 2003
- Progression of Articular Destruction and the Production of Tumour Necrosis Factor‐α in Antigen‐Induced Arthritis in RabbitsScandinavian Journal of Immunology, 1997
- Inhibition of the production and effects of interleukins‐1 and tumor necrosis factor α in rheumatoid arthritisArthritis & Rheumatism, 1995
- Effects of ZCR-2060 on Allergic Airway Inflammation and Cell Activation in Guinea-pigsJournal of Pharmacy and Pharmacology, 1994
- (+)-1-(3S,4R)-[3-(4-Phenylbenzyl)-4- hydroxychroman-7-yl]cyclopentane Carboxylic Acid, a Highly Potent, Selective Leukotriene B4 Antagonist with Oral Activity in the Murine Collagen-Induced Arthritis ModelJournal of Medicinal Chemistry, 1994
- Rheumatoid ArthritisNew England Journal of Medicine, 1990
- Differential effects of steroids on leukocyte-mediated glomerulonephritis in the rabbitKidney International, 1984